A Recap of New Cosmetic Ingredients Notified in China from Q1 to Q3 2023
Since the official implementation of the Cosmetic Supervision and Administration Regulation (CSAR) in 2021, China National Medical Product Administration (NMPA) has implemented classified management on cosmetic products and new cosmetic ingredients (NCIs) according to their risk degree. High-risk NCIs are required to be registered with NMPA. While for low-risk NCIs, as long as enterprises complete the submission of dossiers online, the NCI is considered as “notified” and then can be manufactured and imported, which reduces the threshold for NCI to enter the Chinese market.
